SCHEMBL8292280

SCHEMBL8292280

CCOC(=O)Cc1c(C)n(Cc2ccc(Cl)cc2)c2ccc(OC)cc12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.78
CYP1A2 P05177 2/20 0.78
CYP3A4 P08684 2/20 0.78
CYP2C9 P11712 2/20 0.78
TSHR P16473 2/20 0.78
CYP2C19 P33261 2/20 0.78
PMP22 Q01453 2/20 0.78
PKM P14618 2/20 0.78
HIF1A Q16665 2/20 0.78
MEN1 O00255 1/20 0.78
RGS12 O14924 1/20 0.78
ALDH1A1 P00352 1/20 0.78
MAPT P10636 1/20 0.78
NFKB1 P19838 1/20 0.78
MAPK1 P28482 1/20 0.78
GNAI1 P63096 1/20 0.78
KMT2A Q03164 1/20 0.78
PLA2G2A P14555 8/20 0.73
PTGS2 P35354 8/20 0.70
PLA2G1B P04054 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8296317 0.95 LMNA (0.69) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL8647358 0.93 LMNA (0.77) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL8296825 0.92 LMNA (0.66) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL6437046 0.91 PKM (0.81) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL8877441 0.91 PTGS2 (0.79) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL7962081 0.90 PLA2G2A (0.80) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL7962138 0.90 PLA2G2A (0.79) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL8292089 0.88 PLA2G2A (0.64) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL1322507 0.88 LMNA (1.00) LMNACYP1A2CYP3A4CYP2C9TSHR
SCHEMBL8296798 0.88 PLA2G2A (0.75) LMNACYP1A2CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620214-B1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors LILLY CO ELI (US) 1999-03-03 EP disclosed
US-5578634-A SEPTIC SHOCK TREATMENT ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0620214-A1 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed